Cell & gene therapy
Move vector production forward with a defined research-grade workflow
Order research-grade AAV, lentiviral and retroviral vector production with defined titres, documented QC and predictable turnaround for preclinical work.
What this covers
How research-grade viral vector production works with us
- AAV, lentiviral and retroviral options
- Defined titre targets and QC panel
- Purification formats suited to in vitro or in vivo use
At a glance
- Vector types
- AAV, lentivirus, retrovirus
- Scale
- Research to preclinical batches
- QC
- Titre, purity, sterility, mycoplasma
- Turnaround
- Typically 4–8 weeks by vector type
Service flow
- 1Construct review
- 2Production
- 3Purification & QC
- 4Release
Process
A clear path from enquiry to delivery
- Step 01
Construct review
We confirm design feasibility and packaging limits.
- Step 02
Production
Transfection, expansion and harvest at the agreed scale.
- Step 03
Purification & QC
Purification format and QC panel per specification.
- Step 04
Release
Vector shipped with a full QC report.
Good to know
Research-grade material is not intended for clinical administration.
Talk to us
Tell us what you need and we will scope it with you
Share the essentials and a specialist from the relevant team will respond with next steps, feasibility and indicative timing.
Cell & gene therapy manufacturing services
Related services
Cell & gene therapy
GMP-grade plasmid production
Produce plasmid DNA under GMP conditions for use as starting material in viral vector, mRNA and cell therapy m…
ExploreCell & gene therapy
GMP-grade mRNA production
Move mRNA candidates from research synthesis into GMP production with template supply, capping and purificatio…
ExploreCell & gene therapy
Cell processing support
Get hands-on support for isolation, activation, transduction and expansion steps, using validated reagents and…
ExploreSupport
Not sure which service fits your project?
Our scientists can help you choose between custom development, formatting and manufacturing support.